medline.ch Gynäkologie Mammae

	Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 study. Breast Cancer Res Zou L, Tang X, Deng P, Liu Y, Yang T, Tan X, Yang L, Li W, Zeng X. PMID: 41782020 [PubMed - as supplied by publisher]
	Omitting axillary lymph node dissection or not? A multicenter, retrospective study for breast cancer patients potentially eligible for abemaciclib since the SENOMAC trial. World J Surg Oncol Xu Z, Zeng Y, Shen K, Hu C, Gao W. PMID: 41782017 [PubMed - as supplied by publisher]
	Impact of germline genetic variation on breast cancer prognosis: a systematic review and meta-analysis. BMC Cancer Gutiérrez-González A, Maciel-Cruz EJ, Reynoso-Noverón N, Mohar-Betancourt A, Villarreal-Garza C, Grimaldo L, Trujillo-Martínez M, Gómez-Flores-Ramos L. PMID: 41781907 [PubMed - as supplied by publisher]
	Sonodynamic Therapy-Enhanced Immunotherapy for Triple-Negative Breast Cancer: Mechanistic Advances, Nanoplatform Strategies, and Clinical Prospects. Mol Imaging Biol Tatiparthi R, Panda A, Chaitanya M, Gashe F, Hasan G, Yarlagadda R. PMID: 41781803 [PubMed - as supplied by publisher]
	Finding the optimal recall rate in breast cancer screening: results from the ROCS study. Eur Radiol van der Waal D, Abbey CK, Tetteroo E, Geertse TD, Smid-Geirnaerdt MJA, Sechopoulos I, Broeders MJM. PMID: 41781728 [PubMed - as supplied by publisher]
	Magnification-independent breast cancer diagnosis using a GWO-enhanced vision transformer with multi-stage stain normalization. Sci Rep Fatma T, Sahu PK, Choudhury S, Wunnava A. PMID: 41781597 [PubMed - as supplied by publisher]
	AI-based BRAIx risk score for the intermediate-term prediction of breast cancer: a population cohort study. Lancet Digit Health Frazer HML, Hopper JL, Nguyen TL, Elliott MS, Kunicki KM, Al-Qershi O, Schmidt DF, Makalic E, Li S, Fox SK, Dowty JG, Peña-Solorzano CA, Kwok CF, Chen Y, Wang C, Lippey J, Brotchie P, Carneiro G, Strand F, McCarthy DJ. PMID: 41781282 [PubMed - as supplied by publisher]
	Amide Proton Transfer-Weighted Imaging Combined with Fat Fraction Imaging for Diagnosis of Triple-Negative Breast Cancer. Acad Radiol Yin X, Wang S, Guo Z, Zhang M, Lin L, Zhang L. PMID: 41781261 [PubMed - as supplied by publisher]
	Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease. Ann Oncol Curigliano G, Hu X, Dent R, Yonemori K, Barrios CH, Pierga JY, Puglisi F, Ferrero JM, Jung KH, Bagegni NA, Collignon J, Gil-Gil M, Wu X, Andrzejuk-, Schwaederle M, Anand S, Bardia A. PMID: 41780642 [PubMed - as supplied by publisher]
	Digital breast tomosynthesis and reading with artificial intelligence. Rofo Weigel S, Wunderlich P, Sommer A, Czwoydzinski J, Baltzer PAT, Dewald CLA, Preibsch H, Sauer S, Siegmann-Luz KC, Wenkel E, Wilpert C, Blum SFU. PMID: 41780548 [PubMed - as supplied by publisher]
	Thermal signatures in breast cancer: Deciphering latent biomarkers through deep learning and explainable AI. J Therm Biol Kansal S, Kaur S, Jain A, Bansal S, Gambhir M. PMID: 41780328 [PubMed - as supplied by publisher]
	Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study). J Clin Oncol Li T, Zhou T, Wang B, Tao Z, Zhao M, Wang L, Jin J, Zhao Y, Gong C, Cao J, Miao H, Peng W, Wang J, Jin M, Hu X, Zhang J. PMID: 41779972 [PubMed - as supplied by publisher]
	Integrated strategy for breast cancer biomarker analysis using dual ionic liquid aqueous biphasic systems and microfluidic immunoassays. Lab Chip Mendes MSM, Agostinho I, Souza MC, Chu V, Freire MG, E Silva FA, Conde JP. PMID: 41779543 [PubMed - as supplied by publisher]
	Experience of family caregivers of breast cancer-related lymphedema patients participating in lymphedema management: a phenomenological study. Support Care Cancer Wang Q, Cheng Y, Kong L, Shen X, Chen X, Qian H, Jiang L. PMID: 41779219 [PubMed - in process]
	Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study. Cancer Diagn Progn Fujii T, Ichiba K, Aoki M, Tanabe K, Ogino M, Obayashi S, Takei H. PMID: 41778252 [PubMed]
	Wirsching Psychosocial Risk Scale (WPRS) Versus Outcome in Patients With Breast Disease and Breast Cancer: A Prospective 25-year Follow-up Study in Patients With Breast Cancer Symptoms. Cancer Diagn Progn Eskelinen M, Koskela R, Selander T, Kaarniranta K, Ollonen P, Eskelinen M. PMID: 41778241 [PubMed]
	Consumer perspective on breast density notification in Australia. Ecancermedicalscience Minck S, Evans G, Lowe M, Schultz-Ferguson C, Woulfe C, Berchtenbreiter K, Sullivan K, White A, Moore L, Jarvis S, Ingman WV, Stone J. PMID: 41778188 [PubMed]
	Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya. Ecancermedicalscience El-Mogassabi A, Baiu HS, Hassan NO, Salem EM, Elshakmak L, Tamoos KAK, Zidan M, Rashid ARB, Elhoudiri A, Elmehdawi S, Shareia D. PMID: 41778186 [PubMed]
	Challenges in managing recurrent luminal A breast cancer: a case study. Ecancermedicalscience Hashmi MF, Khan F, Baloyan E, Safaryan L, Zohrabyan D, Tamamyan G, Bardakhchyan S. PMID: 41778178 [PubMed]
	The association between global and prime diet quality scores and the risk of breast cancer: a case control study. Front Public Health Otifi HM, Zacharakis G, Almasabi SHA, Alhazmi K, Kambal N, Alshreef B, Alhajri AS. PMID: 41778127 [PubMed - in process]

Artikel 1 - 20 / 215141

Seite 1 von 10758

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung